SCHEMBL8348779

SCHEMBL8348779

COc1ccc2c(O)nc(-c3ccncc3)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.47
PDGFRA P16234 2/20 0.47
NPC1 O15118 5/20 0.46
RAB9A P51151 4/20 0.44
CASP3 P42574 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
KDM4E B2RXH2 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP17A1 P05093 1/20 0.43
PTGDR Q13258 1/20 0.43
CYP3A4 P08684 1/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
ACP1 P24666 1/20 0.41
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 2/20 0.41
IDH1 O75874 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8272309 0.87 NPC1 (0.57) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL8348782 0.84 NPC1 (0.47) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL13730043 0.84 NPC1 (0.49) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL8352665 0.83 NPC1 (0.64) NPC1RAB9AKDM4ECYP17A1PTGDR
SCHEMBL1536441 0.82 PDGFRB (0.47) PDGFRBPDGFRANPC1RAB9ACASP3
SCHEMBL13728566 0.82 ACP1 (0.47) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL8351874 0.82 APP (0.48) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL28034150 0.82 NPC1 (0.44) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL8186120 0.81 ACP1 (0.45) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL8273106 0.79 CYP1A2 (0.41) PDGFRBNPC1RAB9ACASP3SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1505963-B9 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-09-21 EP disclosed
EP-2340830-A2 Hepatitis C Virus Inhibitors Bristol-Myers Squibb Company (US) 2011-07-06 EP disclosed
EP-1505963-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-04-20 EP disclosed
WO-2003099274-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 WO disclosed